Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers
View ORCID ProfileAng Li, Yi Zi, View ORCID ProfileJiaqi Luo, Xiaobin You, Zhaoji Lan, Tianliangwen Zhou, Yangming Wu, Qihuan Zhi, Huijun Su, Mei Zhu, Siwen Xu, Yun Gao, Zaixuan Zhong, Ling Xie, Yuanqin Wang, Qiuping Lin, Xiaoting Li, Jiamin Zhan, Hui Weng, Dan Li, Shulan Xu, Gang Sun, View ORCID ProfileYujian Shi
doi: https://doi.org/10.1101/2020.07.20.20135202
Ang Li
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Yi Zi
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Jiaqi Luo
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Xiaobin You
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Zhaoji Lan
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Tianliangwen Zhou
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Yangming Wu
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Qihuan Zhi
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Huijun Su
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Mei Zhu
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Siwen Xu
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Yun Gao
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Zaixuan Zhong
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Ling Xie
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Yuanqin Wang
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Qiuping Lin
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Xiaoting Li
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Jiamin Zhan
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Hui Weng
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Dan Li
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Shulan Xu
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Gang Sun
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Yujian Shi
1Top Gene Tech (Guangzhou) Co., Ltd., Guangzhou, P.R.China
Posted July 26, 2020.
Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers
Ang Li, Yi Zi, Jiaqi Luo, Xiaobin You, Zhaoji Lan, Tianliangwen Zhou, Yangming Wu, Qihuan Zhi, Huijun Su, Mei Zhu, Siwen Xu, Yun Gao, Zaixuan Zhong, Ling Xie, Yuanqin Wang, Qiuping Lin, Xiaoting Li, Jiamin Zhan, Hui Weng, Dan Li, Shulan Xu, Gang Sun, Yujian Shi
medRxiv 2020.07.20.20135202; doi: https://doi.org/10.1101/2020.07.20.20135202
Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers
Ang Li, Yi Zi, Jiaqi Luo, Xiaobin You, Zhaoji Lan, Tianliangwen Zhou, Yangming Wu, Qihuan Zhi, Huijun Su, Mei Zhu, Siwen Xu, Yun Gao, Zaixuan Zhong, Ling Xie, Yuanqin Wang, Qiuping Lin, Xiaoting Li, Jiamin Zhan, Hui Weng, Dan Li, Shulan Xu, Gang Sun, Yujian Shi
medRxiv 2020.07.20.20135202; doi: https://doi.org/10.1101/2020.07.20.20135202
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12849)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4653)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2960)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (938)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4441)
- Nursing (239)
- Nutrition (653)
- Oncology (2310)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (328)
- Pain Medicine (286)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7039)
- Radiology and Imaging (1557)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)